GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gufic Biosciences Ltd (NSE:GUFICBIO) » Definitions » Shiller PE Ratio

Gufic Biosciences (NSE:GUFICBIO) Shiller PE Ratio : 67.69 (As of May. 17, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Gufic Biosciences Shiller PE Ratio?

As of today (2025-05-17), Gufic Biosciences's current share price is ₹379.75. Gufic Biosciences's E10 for the quarter that ended in Dec. 2024 was ₹5.61. Gufic Biosciences's Shiller PE Ratio for today is 67.69.

The historical rank and industry rank for Gufic Biosciences's Shiller PE Ratio or its related term are showing as below:

NSE:GUFICBIO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 47.37   Med: 67.32   Max: 99.25
Current: 63.12

During the past years, Gufic Biosciences's highest Shiller PE Ratio was 99.25. The lowest was 47.37. And the median was 67.32.

NSE:GUFICBIO's Shiller PE Ratio is ranked worse than
89.48% of 523 companies
in the Drug Manufacturers industry
Industry Median: 24.68 vs NSE:GUFICBIO: 63.12

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Gufic Biosciences's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹1.930. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹5.61 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Gufic Biosciences Shiller PE Ratio Historical Data

The historical data trend for Gufic Biosciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gufic Biosciences Shiller PE Ratio Chart

Gufic Biosciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 56.78 82.69 47.32 57.81

Gufic Biosciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.81 57.81 66.98 70.97 81.06

Competitive Comparison of Gufic Biosciences's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Gufic Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gufic Biosciences's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gufic Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Gufic Biosciences's Shiller PE Ratio falls into.


;
;

Gufic Biosciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Gufic Biosciences's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=379.75/5.61
=67.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gufic Biosciences's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Gufic Biosciences's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1.93/158.3229*158.3229
=1.930

Current CPI (Dec. 2024) = 158.3229.

Gufic Biosciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 0.143 97.163 0.233
201506 0.130 99.841 0.206
201509 0.210 101.753 0.327
201512 0.310 102.901 0.477
201603 0.286 102.518 0.442
201606 0.330 105.961 0.493
201609 0.340 105.961 0.508
201612 0.400 105.196 0.602
201703 0.100 105.196 0.151
201706 0.460 107.109 0.680
201709 0.710 109.021 1.031
201712 0.810 109.404 1.172
201803 0.390 109.786 0.562
201806 0.770 111.317 1.095
201809 0.790 115.142 1.086
201812 0.760 115.142 1.045
201903 0.800 118.202 1.072
201906 0.880 120.880 1.153
201909 0.550 123.175 0.707
201912 0.900 126.235 1.129
202003 0.585 124.705 0.743
202006 -0.150 127.000 -0.187
202009 1.790 130.118 2.178
202012 1.600 130.889 1.935
202103 1.330 131.771 1.598
202106 3.220 134.084 3.802
202109 2.410 135.847 2.809
202112 2.170 138.161 2.487
202203 2.090 138.822 2.384
202206 2.170 142.347 2.414
202209 2.090 144.661 2.287
202212 2.100 145.763 2.281
202303 1.870 146.865 2.016
202306 2.130 150.280 2.244
202309 2.390 151.492 2.498
202312 2.230 152.924 2.309
202403 1.990 153.035 2.059
202406 2.080 155.789 2.114
202409 2.170 157.882 2.176
202412 1.930 158.323 1.930

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Gufic Biosciences  (NSE:GUFICBIO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Gufic Biosciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Gufic Biosciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Gufic Biosciences Business Description

Traded in Other Exchanges
Address
SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057
Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare; Criticare Life; Ferticare; Spark; Herbal and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral and a proton-pump inhibitor. It derives maximum revenue from India.

Gufic Biosciences Headlines

No Headlines